← GODS Home
Ashwagandha
Ingredient · 5 compounds · 4 conditions

Ashwagandha is profiled across the CytoSolve® knowledge base and mapped to the disease biology it influences — tracing each of its compounds through disease, biological process, molecular pathway and down to individual biomarkers, with source videos and references at each step.

Compare
Add ingredients to compare side-by-side

Comparison

All Compound Disease Biological Process Molecular Pathway
Compound · 3 disease(s) · 6 pathway(s)
Disease · 2 process(es) · 2 pathway(s)
NeuroInflammation1 pathway
TLR4 Signaling
◈ TargetNF-κB
IL-1β, IL-6, and TNF-α
Oxidative Stress1 pathway
Nrf2/ARE Signaling
◈ TargetNrf2
ROS, HO-1
Disease · 1 process(es) · 2 pathway(s)
Inflammation2 pathways
TNF-α/NF-κB Signaling
◈ TargetTNF-α
TNF-α and IL-1β
IL-6 Signaling
◈ TargetIL-6
IL-6, STAT3
Disease · 1 process(es) · 2 pathway(s)
Inflammation2 pathways
NF-κB Signaling
◈ Targetp65
IL-1β, IL-10, TNF-α, COX-2, iNOS
NF-κB/KPNA2/mIR1297 Signaling
◈ TargetP65
TNF-α, IL-17, mIR 1297, KPNA2
Compound · 2 disease(s) · 3 pathway(s)
Disease · 2 process(es) · 2 pathway(s)
Neurotransmitter Imbalance1 pathway
Neurotransmitter Signaling
◈ TargetSerotonin
Serotonin
NeuroInflammation1 pathway
Gut Microbiome-mediated NeuroInflammatory Signaling
◈ TargetIL-6, IL-17
IL-6, IL-17
Disease · 1 process(es) · 1 pathway(s)
Cartilage Degeneration1 pathway
Cathepsin B Signaling
◈ TargetCathepsin B
Cathepsin B
Compound · 1 disease(s) · 1 pathway(s)
Disease · 1 process(es) · 1 pathway(s)
Inflammation1 pathway
MAPK/NF-κB Signaling
◈ Targetp38 MAPK
TNF-α, IL-6
Compound · 1 disease(s) · 1 pathway(s)
Disease · 1 process(es) · 1 pathway(s)
Inflammation1 pathway
JAK1/STAT3/HIF-1α Signaling
◈ TargetJAK1
IL-1β, IL-6, IL-17, and TNF-α
Compound · 1 disease(s) · 1 pathway(s)
Disease · 1 process(es) · 1 pathway(s)
Inflammation1 pathway
NF-κB/STAT3 Signlaing
◈ Targetp-p65◈ Targetp-STAT
IL-6, IL-1β and TNF-α